213 related articles for article (PubMed ID: 21637109)
1. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.
Akinsiku OT; Bansal A; Sabbaj S; Heath SL; Goepfert PA
J Acquir Immune Defic Syndr; 2011 Oct; 58(2):132-40. PubMed ID: 21637109
[TBL] [Abstract][Full Text] [Related]
2. HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.
Jensen SS; Tingstedt JL; Larsen TK; Brandt L; Gerstoft J; Kronborg G; Pedersen C; Fomsgaard A; Karlsson I
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):8-16. PubMed ID: 26761268
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.
Nakiboneka R; Mugaba S; Auma BO; Kintu C; Lindan C; Nanteza MB; Kaleebu P; Serwanga J
Vaccine; 2019 Jan; 37(1):113-122. PubMed ID: 30459072
[TBL] [Abstract][Full Text] [Related]
4. HIV-specific T-cell responses detected in the genital tract of chronically HIV-infected women are largely monofunctional.
Bere A; Denny L; Naicker P; Burgers WA; Passmore JA
Immunology; 2013 Jul; 139(3):342-51. PubMed ID: 23374084
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
Walker-Sperling VE; Buckheit RW; Blankson JN
J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
[TBL] [Abstract][Full Text] [Related]
6. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
7. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.
Hersperger AR; Pereyra F; Nason M; Demers K; Sheth P; Shin LY; Kovacs CM; Rodriguez B; Sieg SF; Teixeira-Johnson L; Gudonis D; Goepfert PA; Lederman MM; Frank I; Makedonas G; Kaul R; Walker BD; Betts MR
PLoS Pathog; 2010 May; 6(5):e1000917. PubMed ID: 20523897
[TBL] [Abstract][Full Text] [Related]
8. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V
Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874
[TBL] [Abstract][Full Text] [Related]
9. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.
Trabattoni D; Piconi S; Biasin M; Rizzardini G; Migliorino M; Seminari E; Boasso A; Piacentini L; Villa ML; Maserati R; Clerici M
AIDS; 2004 Apr; 18(6):859-69. PubMed ID: 15060433
[TBL] [Abstract][Full Text] [Related]
10. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
[TBL] [Abstract][Full Text] [Related]
11. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
12. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
13. HIV Controllers Exhibit Effective CD8
Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
[TBL] [Abstract][Full Text] [Related]
14. CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
Lécuroux C; Girault I; Chéret A; Versmisse P; Nembot G; Meyer L; Rouzioux C; Pancino G; Venet A; Sáez-Cirión A;
PLoS One; 2013; 8(3):e59767. PubMed ID: 23555774
[TBL] [Abstract][Full Text] [Related]
15. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function.
Chevalier MF; Jülg B; Pyo A; Flanders M; Ranasinghe S; Soghoian DZ; Kwon DS; Rychert J; Lian J; Muller MI; Cutler S; McAndrew E; Jessen H; Pereyra F; Rosenberg ES; Altfeld M; Walker BD; Streeck H
J Virol; 2011 Jan; 85(2):733-41. PubMed ID: 21047960
[TBL] [Abstract][Full Text] [Related]
16. Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
Chiu CY; Chang JJ; Dantanarayana AI; Solomon A; Evans VA; Pascoe R; Gubser C; Trautman L; Fromentin R; Chomont N; McMahon JH; Cameron PU; Rasmussen TA; Lewin SR
J Immunol; 2022 Jan; 208(1):54-62. PubMed ID: 34853078
[TBL] [Abstract][Full Text] [Related]
17. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment.
Huang S; Dunkley-Thompson J; Tang Y; Macklin EA; Steel-Duncan J; Singh-Minott I; Ryland EG; Smikle M; Walker BD; Christie CD; Feeney ME
J Immunol; 2008 Dec; 181(11):8103-11. PubMed ID: 19018003
[TBL] [Abstract][Full Text] [Related]
19. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
20. IL-21 Expands HIV-1-Specific CD8
Wu K; Zhang S; Zhang X; Li X; Hong Z; Yu F; Liu B; Pan T; Huang Z; Tang XP; Cai W; Xia J; Li X; Zhang H; Zhang Y; Li L
J Immunol Res; 2019; 2019():1801560. PubMed ID: 31183385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
